Inhibitory effects of neurotransmitters and steroids on human CYP2A6
Inhibitory effects of neurotransmitters and steroids on human CYP2A6
复制标题
DOI:
10.1124/dmd.106.014084
复制
发表时间:
2007-04-01
影响因子:
3.9
通讯作者:
Yokoi, Tsuyoshi
中科院分区:
文献类型:
--
作者:
Higashi, Eriko;Nakajima, Miki;Yokoi, Tsuyoshi
Human CYP2A6 catalyzes the metabolism of nicotine, cotinine, and coumarin as well as some pharmaceutical drugs. CYP2A6 is highly expressed in liver and, also, in brain and steroid-related tissues. In this study, we investigated the inhibitory effects of neurotransmitters and steroid hormones on CYP2A6 activity. We found that coumarin 7-hydroxylation and cotinine 3'-hydroxylation by recombinant CYP2A6 expressed in baculovirus-infected insect cells were competitively inhibited by tryptamine ( both K-i = 0.2 mu M), serotonin (K-i = 252 mu M and 167 mu M), dopamine (K-i = 49 mu M and 22 mu M), and histamine (K-i = 428 mu M and 359 mu M). Cotinine formation from nicotine was inhibited by tryptamine ( K-i = 0.7 mu M, competitive), serotonin (K-i = 272 mu M, noncompetitive), dopamine, noradrenaline, and adrenaline (K-i = 11 mu M, 54 mu M, and 81 mu M, uncompetitive). Estrogens ( K-i = 0.6 - 3.8 mu M), androgens ( K-i = 60-149 M), and corticosterone ( K-i = 36 mu M) also inhibited cotinine formation, but coumarin 7-hydroxylation and cotinine 3'-hydroxylation did not. Nicotine-Delta(5'(1'))- iminium ion formation from nicotine was not affected by these steroid hormones, indicating that the inhibition of cotinine formation was due to the inhibitory effects on aldehyde oxidase. The nicotine-Delta(5'(1'))-iminium ion formation was competitively inhibited by tryptamine ( K-i = 0.3 mu M), serotonin ( K-i = 316 mu M), dopamine ( K-i = 66 mu M), and histamine ( K-i = 209 mu M). Thus, we found that some neurotransmitters inhibit CYP2A6 activity, being related with inter- and intraindividual differences in CYP2A6-dependent metabolism. The inhibitory effects of steroid hormones on aldehyde oxidase may also contribute to interindividual differences in nicotine metabolism.